UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): October 29, 2008
SILICON LABORATORIES INC.
(Exact Name of Registrant as Specified in Charter)
Delaware |
|
000-29823 |
|
74-2793174 |
(State or Other Jurisdiction |
|
(Commission File Number) |
|
(IRS Employer |
of Incorporation) |
|
|
|
Identification No.) |
400 West Cesar Chavez, Austin, TX 78701
(Address of Principal Executive Offices) (Zip Code)
Registrants telephone number, including area code: (512) 416-8500
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02. Results of Operations and Financial Condition
On October 29, 2008, Silicon Laboratories Inc. (Silicon Laboratories) issued a press release describing its results of operations for its fiscal quarter ended October 4, 2008. A copy of the press release is attached as Exhibit 99 to this report.
Item 8.01. Other Events
On October 29, 2008, Silicon Laboratories also announced in its press release that its Board of Directors authorized an additional share repurchase program having an aggregate value of up to $100 million over a period of 12 months.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits.
99 Press Release of Silicon Laboratories Inc. dated October 29, 2008.
Use of Non-GAAP Financial Information
From time to time, Silicon Laboratories provides certain non-GAAP financial measures as additional information relating to its operating results. The non-GAAP financial measurements provided in the press release furnished herewith do not replace the presentation of Silicon Laboratories GAAP financial results. These additional measurements merely provide supplemental information to assist investors in analyzing Silicon Laboratories financial position and results of operations; however, these measures are not in accordance with, or an alternative to, GAAP and may be different from non-GAAP measures used by other companies. Silicon Laboratories has chosen to provide this information to investors because it believes that such supplemental information enables them to perform meaningful comparisons of past, present and future operating results, and as a means to highlight the results of core ongoing operations.
Pursuant to the requirements of Regulation G, we have provided in the press release furnished with this report a reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measures.
The information in this report, including the exhibit hereto, shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section. The information contained therein and in the accompanying exhibit shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission made by Silicon Laboratories, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
SILICON LABORATORIES INC. |
|
|
|
|
|
|
October 29, 2008 |
|
/s/ Paul V. Walsh, Jr. |
Date |
|
Paul V. Walsh, Jr. |
3
EXHIBIT INDEX
Exhibit No. |
|
Description |
|
|
|
99 |
|
Press release dated October 29, 2008 of the Registrant |
4
Exhibit 99
SILICON LABORATORIES REPORTS STRONG TOP AND BOTTOM LINE PERFORMANCE
Company Grows Revenue by 29 Percent, Achieves Model Performance and Announces Additional $100 million Share Repurchase Authorization
AUSTIN, Texas Oct. 29, 2008 Silicon Laboratories Inc. (Nasdaq: SLAB), a leader in high-performance, analog-intensive, mixed-signal integrated circuits (ICs), today reported third quarter revenue of $113.5 million, a 29 percent increase over the same period last year. The company controlled operating expense growth and delivered strong gross margins, resulting in better than anticipated operating income and earnings per share results.
The companys Board of Directors also approved a $100 million share repurchase program with a twelve month expiration. This additional authorization reflects the Boards confidence in the business and the companys view that the stock is significantly undervalued. The program may be executed on the open market or in private transactions, including structured or accelerated transactions, depending on market conditions.
Financial Results
The company executed well during the quarter. Revenue of $113.5 million represented an 8.5 percent sequential increase. GAAP results, which are inclusive of the impact of the acquisition of Integration Associates, were generally better than forecasted. GAAP gross margin was 61.1 percent, GAAP operating income was $7.3 million, and GAAP diluted earnings per share were two cents. GAAP earnings include charges related to the write-off of in-process research and development, the fair value mark up of cost of sales for the quarter, and a tax expense associated with incorporating the acquisition into the companys international operating structure. As is typical, the GAAP results also include the impact of stock compensation expense of $10 million, which was flat relative to the prior period despite the acquisition during the quarter.
The following non-GAAP results exclude the previously detailed charges. A non-GAAP gross margin of 62.4 percent was again above the companys target range of 60 to 62 percent. Operating expenses were slightly lower than expected, resulting in an increase of non-GAAP operating income to $29.0 million or 25.5 percent of revenue, exceeding the companys target model. Non-GAAP diluted earnings per share from continuing operations were $0.68, representing a greater than 50 percent year over year increase. Excluding one time tax benefits, non-GAAP diluted earnings per share were $0.49, well above the guidance due to the strong gross margin performance and controlled spending. The reconciling charges are set forth in the financial measures table included below.
During the third quarter, the company continued execution of its share repurchase program completing repurchases totaling $69 million, closed the acquisition of Integration Associates and generated another $36 million in cash flow, bringing the quarter-ending cash, cash equivalents and investments balance to $336 million.
Business Summary
Strong revenue growth in the third quarter was due to strength in the RF business, driven primarily by the companys broadcast audio products. Both handset and non-handset revenue were up double-digits sequentially as the company continued to gain market share. Total design wins also accelerated during the quarter and penetration rates of FM radio in handsets increased. The company began marketing newly acquired EZRadio® short-range wireless products to customers and expects this to be an important growth area in 2009.
The companys broad-based business was up nearly 50 percent year-over-year led by the timing products. A growing customer base, strong acceptance of new clock and oscillator products and the addition of new, revolutionary products have created significant momentum for the timing portfolio. The MCU products were somewhat impacted by slowing end-market demand, but the company continued to introduce new products to market and secure design wins in new applications. Power, an emerging growth area for the company, became meaningful during the quarter as customers adopted the companys isolator products. The company is also benefiting
from the addition of new ac/dc products to the power portfolio.
Q3 was another excellent quarter. Our business operated at model performance, with expanded earnings and strong cash generation, said Necip Sayiner, president and CEO of Silicon Laboratories. Looking ahead, we believe that with operating expenses well controlled and a strong competitive position with our customers, we have the ability to manage through this difficult market environment. We are executing to our long-term vision, which is to deliver disruptive products to market, gain market share and profitably grow our business in excess of our peers.
The company guided revenue for the fourth quarter to be flat to down five percent sequentially.
Webcast and Conference Call
A conference call discussing the third quarter results will follow this press release today at 7:30 a.m. Central Time. An audio webcast will be available simultaneously on Silicon Laboratories website under Investor Relations (www.silabs.com). A replay will be available after the call at the same website listed above or by calling 1-800-294-9508 or +1 203-369-3795 (international). Replays will be available through November 12, 2008.
About Silicon Laboratories Inc.
Silicon Laboratories Inc. is a leading designer of high-performance, analog-intensive, mixed-signal integrated circuits (ICs) for a broad range of applications. Silicon Laboratories diverse portfolio of highly integrated, patented solutions is developed by a world-class engineering team with expertise in cutting-edge mixed-signal design. The company has design, engineering, marketing, sales and applications offices throughout North America, Europe and Asia. For more information about Silicon Laboratories, please visit www.silabs.com.
Forward Looking Statements
This press release contains forward-looking statements based on Silicon Laboratories current expectations. The words believe, estimate, expect, intend, anticipate, plan, project, will and similar phrases as they relate to Silicon Laboratories are intended to identify such forward-looking statements. These forward-looking statements reflect the current
views and assumptions of Silicon Laboratories and are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. Among the factors that could cause actual results to differ materially from those in the forward-looking statements are the following: risks that Silicon Laboratories may not be able to maintain its historical growth; quarterly fluctuations in revenues and operating results; volatile stock price; average selling prices of products may decrease significantly and rapidly, dependence on a limited number of products and customers; difficulties developing new products that achieve market acceptance; risks that Silicon Laboratories may not be able to manage strains associated with its growth; dependence on key personnel; difficulties managing our manufacturers and subcontractors; difficulties managing international activities; credit risks associated with our accounts receivable; geographic concentration of manufacturers, assemblers, test service providers and customers in Asia that subjects Silicon Laboratories business and results of operations to risks of natural disasters, epidemics, war and political unrest; product development risks; inventory-related risks; intellectual property litigation risks; risks associated with acquisitions (including risks that acquisitions may not yield the expected benefits due to the failure to properly integrate the acquired businesses and employees; risks that the customer base and revenue of the acquired businesses may cease to expand or may decline; risks that the acquired business products under development may fail to achieve market acceptance; risks of disputes regarding the acquired business; risks that the performance of Silicon Laboratories existing business may not offset the dilutive effect of an acquisition); risks associated with divestitures; the competitive and cyclical nature of the semiconductor industry and other factors that are detailed in Silicon Laboratories filings with the SEC. Silicon Laboratories disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Note to editors: Silicon Laboratories, Silicon Labs, EZRadio and the Silicon Labs logo are trademarks of Silicon Laboratories Inc. All other product names noted herein may be trademarks of their respective holders.
CONTACT: Silicon Laboratories Inc., Shannon Pleasant, (512) 464 9254, shannon.pleasant@silabs.com
Silicon Laboratories Inc.
Condensed Consolidated Statements of Income
(In thousands, except per share data)
(Unaudited)
|
|
Three Months Ended |
|
Nine Months Ended |
|
||||||||
|
|
October 4, |
|
September 29, |
|
October 4, |
|
September 29, |
|
||||
Revenues |
|
$ |
113,483 |
|
$ |
87,938 |
|
$ |
316,282 |
|
$ |
237,349 |
|
Cost of revenues |
|
44,174 |
|
34,986 |
|
120,593 |
|
93,658 |
|
||||
Gross profit |
|
69,309 |
|
52,952 |
|
195,689 |
|
143,691 |
|
||||
Operating expenses: |
|
|
|
|
|
|
|
|
|
||||
Research and development |
|
25,785 |
|
20,844 |
|
73,836 |
|
67,796 |
|
||||
Selling, general and administrative |
|
25,940 |
|
21,693 |
|
75,035 |
|
67,267 |
|
||||
In-process research and development |
|
10,250 |
|
|
|
10,250 |
|
|
|
||||
Operating expenses |
|
61,975 |
|
42,537 |
|
159,121 |
|
135,063 |
|
||||
Operating income |
|
7,334 |
|
10,415 |
|
36,568 |
|
8,628 |
|
||||
Other income (expense): |
|
|
|
|
|
|
|
|
|
||||
Interest income |
|
2,073 |
|
7,136 |
|
9,277 |
|
18,003 |
|
||||
Interest expense |
|
(71 |
) |
(129 |
) |
(325 |
) |
(527 |
) |
||||
Other income (expense), net |
|
(43 |
) |
(214 |
) |
(540 |
) |
(384 |
) |
||||
Income from continuing operations before income taxes |
|
9,293 |
|
17,208 |
|
44,980 |
|
25,720 |
|
||||
Provision (benefit) for income taxes |
|
8,139 |
|
(416 |
) |
18,369 |
|
1,950 |
|
||||
Income from continuing operations |
|
1,154 |
|
17,624 |
|
26,611 |
|
23,770 |
|
||||
Income from discontinued operations, net of income taxes |
|
|
|
2,810 |
|
|
|
159,750 |
|
||||
|
|
|
|
|
|
|
|
|
|
||||
Net income |
|
$ |
1,154 |
|
$ |
20,434 |
|
$ |
26,611 |
|
$ |
183,520 |
|
Basic earnings per share: |
|
|
|
|
|
|
|
|
|
||||
Income from continuing operations |
|
$ |
0.02 |
|
$ |
0.32 |
|
$ |
0.54 |
|
$ |
0.43 |
|
Net income |
|
$ |
0.02 |
|
$ |
0.37 |
|
$ |
0.54 |
|
$ |
3.34 |
|
|
|
|
|
|
|
|
|
|
|
||||
Diluted earnings per share: |
|
|
|
|
|
|
|
|
|
||||
Income from continuing operations |
|
$ |
0.02 |
|
$ |
0.31 |
|
$ |
0.53 |
|
$ |
0.42 |
|
Net income |
|
$ |
0.02 |
|
$ |
0.36 |
|
$ |
0.53 |
|
$ |
3.25 |
|
|
|
|
|
|
|
|
|
|
|
||||
Weighted-average common shares outstanding: |
|
|
|
|
|
|
|
|
|
||||
Basic |
|
47,331 |
|
55,215 |
|
49,036 |
|
54,996 |
|
||||
Diluted |
|
48,385 |
|
56,767 |
|
50,083 |
|
56,481 |
|
Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures
(In thousands, except per share data)
|
|
Three Months Ended |
|
|||||||||||||||||
Non-GAAP Income |
|
GAAP |
|
GAAP |
|
Stock |
|
In-process |
|
Cost of Sales |
|
Non-GAAP |
|
Non-GAAP |
|
|||||
Revenues |
|
$ |
113,483 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Gross profit |
|
69,309 |
|
61.1 |
% |
$ |
100 |
|
$ |
|
|
$ |
1,398 |
|
$ |
70,807 |
|
62.4 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Operating income |
|
7,334 |
|
6.5 |
% |
9,996 |
|
10,250 |
|
1,398 |
|
28,978 |
|
25.5 |
% |
|||||
|
|
Three Months Ended |
|
|
|
||||||||||||||||
Non-GAAP Diluted |
|
GAAP |
|
Acquisition |
|
Stock |
|
In-process |
|
Cost of Sales |
|
Non-GAAP |
|
|
|
||||||
Income from continuing operations |
|
$ |
1,154 |
|
$ |
11,756 |
|
$ |
8,646 |
|
$ |
10,250 |
|
$ |
909 |
|
$ |
32,715 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Diluted shares outstanding |
|
48,385 |
|
|
|
|
|
|
|
|
|
48,385 |
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Diluted earnings per share from continuing operations |
|
$ |
0.02 |
|
|
|
|
|
|
|
|
|
$ |
0.68 |
|
|
|
||||
Non-GAAP Diluted |
|
Three Months Ended |
|
|||||||||||||||||||
Earnings Per Share |
|
GAAP |
|
Acquisition |
|
Stock |
|
In-process |
|
Cost of Sales |
|
One Time |
|
Non-GAAP |
|
|||||||
Income from continuing operations |
|
$ |
1,154 |
|
$ |
11,756 |
|
$ |
8,646 |
|
$ |
10,250 |
|
$ |
909 |
|
$ |
(9,051 |
) |
$ |
23,664 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Diluted shares outstanding |
|
48,385 |
|
|
|
|
|
|
|
|
|
|
|
48,385 |
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Diluted earnings per share from continuing operations |
|
$ |
0.02 |
|
|
|
|
|
|
|
|
|
|
|
$ |
0.49 |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
|
Three Months Ended |
|
|
|
|
|
|
|
|
|
|||||||||||
Non-GAAP Diluted |
|
GAAP |
|
Stock |
|
Non-GAAP |
|
|
|
|
|
|
|
|
|
|||||||
Income from continuing operations |
|
$ |
17,624 |
|
$ |
7,013 |
|
$ |
24,637 |
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Diluted shares outstanding |
|
56,767 |
|
|
|
56,767 |
|
|
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Diluted earnings per share from continuing operations |
|
$ |
0.31 |
|
|
|
$ |
0.43 |
|
|
|
|
|
|
|
|
|
|||||
Silicon Laboratories Inc.
Condensed Consolidated Balance Sheets
(In thousands, except per share data)
|
|
October 4, |
|
December 29, |
|
||
|
|
(Unaudited) |
|
|
|
||
Assets |
|
|
|
|
|
||
Current assets: |
|
|
|
|
|
||
Cash and cash equivalents |
|
$ |
151,311 |
|
$ |
264,408 |
|
Short-term investments |
|
131,496 |
|
308,566 |
|
||
Accounts receivable, net of allowance for doubtful accounts of $1,004 at October 4, 2008 and $517 at December 29, 2007 |
|
61,601 |
|
51,211 |
|
||
Inventories |
|
34,360 |
|
28,587 |
|
||
Deferred income taxes |
|
6,003 |
|
6,025 |
|
||
Prepaid expenses and other current assets |
|
11,451 |
|
33,895 |
|
||
Total current assets |
|
396,222 |
|
692,692 |
|
||
Long-term investments |
|
53,367 |
|
|
|
||
Property, equipment and software, net |
|
29,372 |
|
28,157 |
|
||
Goodwill |
|
107,494 |
|
73,199 |
|
||
Other intangible assets, net |
|
51,707 |
|
18,077 |
|
||
Other assets, net |
|
22,194 |
|
28,121 |
|
||
Total assets |
|
$ |
660,356 |
|
$ |
840,246 |
|
|
|
|
|
|
|
||
Liabilities and Stockholders Equity |
|
|
|
|
|
||
Current liabilities: |
|
|
|
|
|
||
Accounts payable |
|
$ |
32,407 |
|
$ |
33,321 |
|
Accrued expenses |
|
23,137 |
|
26,397 |
|
||
Deferred income on shipments to distributors |
|
29,413 |
|
28,448 |
|
||
Income taxes |
|
4,688 |
|
5,226 |
|
||
Total current liabilities |
|
89,645 |
|
93,392 |
|
||
Long-term obligations and other liabilities |
|
45,537 |
|
43,309 |
|
||
Total liabilities |
|
135,182 |
|
136,701 |
|
||
|
|
|
|
|
|
||
Commitments and contingencies |
|
|
|
|
|
||
|
|
|
|
|
|
||
Stockholders equity: |
|
|
|
|
|
||
Preferred stock$0.0001 par value; 10,000 shares authorized; no shares issued and outstanding |
|
|
|
|
|
||
Common stock$0.0001 par value; 250,000 shares authorized; 46,251 and 52,810 shares issued and outstanding at October 4, 2008 and December 29, 2007, respectively |
|
5 |
|
5 |
|
||
Additional paid-in capital |
|
102,736 |
|
303,682 |
|
||
Retained earnings |
|
426,469 |
|
399,858 |
|
||
Accumulated other comprehensive loss |
|
(4,036 |
) |
|
|
||
Total stockholders equity |
|
525,174 |
|
703,545 |
|
||
Total liabilities and stockholders equity |
|
$ |
660,356 |
|
$ |
840,246 |
|
# # #